Early perturbations in keratin and actin gene expression and fibrillar organisation in griseofulvin-fed mouse liver

Journal of Hepatology

Volumn 33, Issue 2, 2000, Pages 199-207

  Cadrin, Monique ^a   Hovington, Hélène ^a   Marceau, Normand ^b   McFarlane Anderson, Norma ^c  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Actin; Cytoskeleton; Keratin; Liver disease; Mallory body

Indexed keywords

ACTIN; GRISEOFULVIN; KERATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTASIS; CYTOSKELETON; FEEDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIVER DISEASE; MALE; MALLORY BODY; MORPHOLOGY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0033915332     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80360-8     Document Type: Article

References (65)

1. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 31:1982;11-24.
2. Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem. 57:1988;593-625.
3. McLean WHI, Lane EB. Intermediate filaments in disease. Curr Opin Cell Biol. 7:1995;118-125.
4. Omary MB, Ku NO. Intermediate filament proteins of the liver: emerging disease association and functions. Hepatology. 25:1997;1043-1048.
5. Ku NO, Michie S, Oshima RG, Omary MB. Chronic hepatitis, hepatocyte fragiliy, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol. 131:1995;1303-1314.
6. Alberts KM, Davies FE, Perrone TN, Lee EY, Liu Y, Vore M. Expression of an epidermal keratin in liver of transgenic mice causes structural and functional abnormalities. J Cell Biol. 128:1995;157-169.
7. Baribault H, Price J, Miyai K, Oshima RG. Mid-gestional lethality in mice lacking keratin 8. Genes Dev. 7:1992;1991-2002.
8. Baribault H, Penner J, Iozzo RV, Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8:1994;2964-2973.
9. Loranger A, Duclos S, Grenier A, Price J, Wilson-Heiner M, Baribault H, et al. Simple epithelium keratins are required for maintenance of hepatocytes integrity. Am J Pathol. 151:1997;1678-1683.
10. Ku NO, Michie SA, Soetikno RM, Resurreccion EZ, Broome RL, Omary MB. Mutation of a major keratin phosphorylation site predispose to hepatotoxic injury in transgenic mice. J Cell Biol. 143:1998;2023-2032.
11. Cadrin M, Marceau N, Baribault H. Griseofulvin hepatotoxicity related effect in keratin 8 deficient FVB/N mice. [abstract] Mol Biol Cell. 6:1995;374a.
12. Satoh MI, Hovington H, Cadrin M. Increased sensitivity of hepatocytes to griseofulvin intoxication in heterozygous keratin 8 deficient (+/-) FVB/N mice. [abstract] Mol Biol Cell. 7:1996;53a.
13. French SW, Okanoue T, Swierenga SHH, Marceau N. The cytoskeleton of hepatocytes in health and disease. Faber E, Phillips MJ. Pathogenesis of Liver Disease. 1987;95-112 Baltimore, Williams & Wilkins.
14. Jensen K, Gluud C. The Mallory body: morphological, clinical and experimental studies (part 1 of a literature survey). Hepatology. 20:1994;1061-1077.
15. Phillips J, Satir P. The cytoskeleton of the hepatocyte: organization, relationships, and pathology. Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA. The Liver: Biology and Pathobiology. 1988;11-27 Raven Press, Ltd, New York.
16. Denk H, Franke WW, Kerjaschki D, Eckerstorfer R. Mallory bodies in experimental animals and man. Int Rev Exp Path. 20:1979;77-120.
17. Denk H, Gschnait F, Wolff K. Hepatocellular hyalin (Mallory bodies) in long term griseofulvin-treated mice: a new experimental model for the study of hyalin formation. Lab Invest. 32:1975;773-776.
18. Kimoff RJ, Huang S-N. Immunocytochemical and immunoelectron microscopic study on Mallory bodies. Lab Invest. 45:1981;491-503.
19. French SW. The Mallory body: structure, composition, and pathogenesis. Hepatology. 1:1981;76-83.
20. Franke WW, Denk H, Schmid E, Osborn M, Weber K. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Lab Invest. 40:1979;207-218.
21. Denk H, Krepler R, Lackinger E, Artlieb U, Franke WW. Immunological and biochemical characterization of the keratin-related component of Mallory bodies: a pathological pattern of hepatocytic cytokeratins. Liver. 2:1982;165-175.
22. Cadrin M, Kawahara H, Ohta M, Katsuma Y, Marceau N, French SW. Mallory bodies in hepatomas and hyperplastic nodules: in vitro and in vivo studies. Prog Clin Biol Res. 331:1990;231-248.
23. Luisada-Opper AV, Kanagasundaram N, Leevy CM. Chemical nature of alcoholic hyalin. Gastroenterol. 73:1977;1374-1376.
24. Cadrin M, Marceau N, French SW. Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice. J Hepatol. 14:1992;226-231.
25. Zatloukal K, Denk H, Spurej G, Lackinger E, Preisegger K-H, Franke WW. High molecular weight component of Mallory bodies detected by a monoclonal antibody. Lab Invest. 62:1990;427-434.
26. Ohta M, Marceau N, Perry G, Manetto V, Gambetti P, Autilio Gambetti L, et al. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest. 59:1988;848-856.
27. Denk H, Zatloukal K, Preisegger K-H. Ubiquitin - a common denominator in intermediate filament pathology of brain and liver? Hepatology. 10:1989;514-521.
28. Zatloukal K, Fesus L, Denk H, Tarcsa E, Spurej G, Böck G. High amount of γ glutamyl ε-lysine cross-links in Mallory bodies. Lab Invest. 66:1992;774-777.
29. Osborn M, Weber K. Keratins, transglutaminase, and Mallory bodies: the really insoluble stuff. Lab Invest. 61:1989;585-587.
30. Katsuma Y, Swierenga SHH, Khettry U, Marceau N, French SW. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Hepatology. 7:1987;1215-1223.
31. Hazan R, Denk H, Franke WW, Lackinger E, Schiller DL. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest. 54:1986;543-553.
32. Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express"bile duct-type" cytokeratins. Histopathology. 13:1988;605-617.
33. Cadrin M, French SW, Wong PTT. Alteration in molecular structure of cytoskeleton proteins in griseofulvin-treated mouse liver: a pressure tuning infrared spectroscopy study. Exp Mol Pathol. 55:1991;170-179.
34. Kachi K, Wong PTT, French SW. Molecular structural changes in Mallory body proteins in human and mouse livers: an infrared spectroscopy study. Exp Mol Pathol. 59:1993;197-210.
35. Boller K, Kemler R, Baribault H, Doetschman T. Differential distribution of cytokeratins after microinjection of anti-cytokeratin monoclonal antibodies. Eur J Cell Biol. 43:1987;459-468.
36. Kemler R, Brulet P, Schnebelen M-T, Gaillard J, Jacob F. Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J Embryol Exp Morphol. 64:1981;45-60.
37. Chomczynski P, Saachi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
38. Singer PA, Trevor D, Oshima RG. Molecular cloning and characterization of endo B cytokeratin expressed in preimplantation mouse embryos. J Biol Chem. 261:1986;538-547.
39. Brûlet P, Jacob F. Molecular cloning of a cDNA sequence encoding a trophectoderm-specific marker during mouse blastocyst fromation. Proc Natl Acad Sci USA. 79:1982;2328-2332.
40. Cleveland DW, Lepota MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW. Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell. 20:1980;95-105.
41. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
42. Sandermann H, Strominger J. Purification and properties of C55-isopronoid alcohol phosphokinase from Staphylococus aureus. J Biol Chem. 247:1972;5123-5131.
43. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
44. Kimoff RJ, Sci B, Huang S-N. Immunocytochemical and immunoelectron microscopic studies on Mallory bodies. Lab Invest. 45:1981;491-503.
45. Yokoo H, Craig RM, Harwood TR, Cochrane C. Griseofulvin-induced cholestasis in Swiss Albino mice. Gastroenterology. 77:1979;1082-1087.
46. Denk H, Franke WW, Eckerstorfer R, Schmid E, Kerjaschki D. Formation and involution of Mallory bodies ("alcoholic hyalin") in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin. Proc Natl Acad Sci USA. 76:1979;4112-4116.
47. Denk H, Franke WW. Rearrangement of the hepatocyte cytoskeleton after toxic damage: involution, dispersal and peripheral accumulation of Mallory body material after drug withdrawal. Eur J Cell Biol. 23:1981;241-249.
48. Zatloukal K, Spurej G, Rainer I, Lackinger E, Denk H. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse. Hepatology. 11:1990;652-661.
49. Yuan QX, Marceau N, French B, Fu P, French SW. Mallory body induction in drug-primed mouse liver. Hepatology. 24:1996;603-612.
50. Cary RB, Klymkowsky MW, Evans RM, Domingo A, Dent JA, Backhus LE. Vimentin's tail interacts with actin-containing structures in vivo. J Cell Sci. 107:1994;1609-1622.
51. Hall PF, Almahbobi G. Roles of microfilaments and intermediate filaments in adrenal steroidogenesis. Microsc Res Tech. 36:1997;463-479.
52. Yang Y, Dowling J, Yu Q-C, Kouklis P, Cleveland DW, Fuchs E. An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell. 86:1996;655-665.
53. Ohta M, Marceau N, French SW. Pathologic changes in the cytokeratin pericanalicular sheath in experimental cholestasis and alcoholic fatty liver. Lab Invest. 59:1988;60-74.
54. Ohta M, Marceau N, French SW. Changes in the organization and antigenic determinants of intermediate filaments of rat hepatocytes after infusion of cytochalasin B in vivo. Am J Pathol. 133:1988;578-588.
55. Mullhaupt B, Gudat F, Epper R, Bianchi L. The common pattern of cytokeratin alteration in alcoholic and cholestatic liver disease is different from that of hepatitic liver damage. A study with the panepithelial monoclonal antibody Lu-5. J Hepatol. 19:1993;23-35.
56. Phillips J, Poucell S, Oda M. Biology of disease. Mechanisms of cholestasis. Lab Invest. 54:1986;593-608.
57. Kawahara H, Cadrin M, Perry G, Autillo-Gambetti L, Swierenga SHH, Metuzals J, et al. Role of cytokeratin intermediate filaments in transhepatic transport and canalicular secretion. Hepatology. 11:1990;435-448.
58. Hutter H, Zatloukal K, Winter G, Stumptner C, Denk H. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver. Lab Invest. 69:1993;576-582.
59. Blouin R, Swierenga SHH, Marceau N. Evidence for post-transcriptional regulation of keratin gene expression in rat liver epithelial cell line. Biochem Cell Biol. 70:1992;1-10.
60. McCarthy JEG, Kollmus H. Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. TIBS. 20:1995;191-197.
61. Ruiz-Echevarria MJ, Czaplinski K, Peltz SW. Masking sense of nonsense in yeast. TIBS. 21:1996;433-438.
62. Cadrin M, McFarlane-Anderson N, Aasheim LH, Kawahara H, Franks DJ, French SW. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Lab Invest. 72:1995;1-8.
63. Zatloukal K, Denk H, Lackinger E, Rainer I. Hepatocellular cytokeratin as substrates of transglutaminases. Lab Invest. 61:1989;603-608.
64. Cadrin M, Pardasani D, McFarlane-Anderson N. Cytokeratin and ubiquitin expression in livers from mice fed griseofulvin. Mol Biol Cell. 4:1993;280a.
65. Salmhofer H, Rainer I, Zatloukal K, Denk H. Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations. Hepatology. 20:1994;731-740.